Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79382 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Citalopram Related Compound H (3-[5-Bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine hydrobromide)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C19H21BrFNO·HBrCor e Forma:White Off-White Crystalline PowderPeso molecular:377.07906Clomipramine Related Compound C (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C19H21ClN2·HClCor e Forma:Yellow PowderPeso molecular:312.13933Abacavir Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:PowderIohexol Related Compound C (N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H19N3O8Cor e Forma:White PowderPeso molecular:357.117214-Methoxymeloxicam (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C15H15N3O4S2Cor e Forma:Yellow PowderPeso molecular:365.0504Gatifloxacin Related Compound D (1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Products described in u.s. note 3 to section 6 containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C18H20FN3O4Cor e Forma:SolidPeso molecular:361.14378Famciclovir Related Compound B (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C12H17N5O3Cor e Forma:Off-White PowderPeso molecular:279.13314Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFórmula:C23H26N2O5Cor e Forma:White PowderPeso molecular:410.18417Acyclovir Related Compound F (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H13N5O4Cor e Forma:White Yellow Crystalline PowderPeso molecular:267.09675Zoledronic Acid Related Compound B (1-Hydroxy-2-[1-(2-hydroxy-2,2-diphosphonoethyl)-1H-imidazol-3-ium-3-yl]-1-phosphonoethylphosphonate)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C7H16N2O14P4Cor e Forma:White PowderPeso molecular:475.9552Ticlopidine Related Compound B (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H12ClNOSCor e Forma:White PowderPeso molecular:277.03281Gadodiamide Related Compound A (Gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide)
CAS:Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, nesoi (excluding cerium compounds)Fórmula:C15H22GdN4NaO9Cor e Forma:White Off-White Pale Yellow PowderPeso molecular:583.05256Cefotaxime Related Compound E ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H13N5O5S2Cor e Forma:Off-White Light Yellow PowderPeso molecular:395.03581Valacyclovir Related Compound C (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H22N6O4·HClCor e Forma:White PowderPeso molecular:338.17025Febuxostat Related Compound C (Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate)
CAS:<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Fórmula:C14H12N2O3SCor e Forma:Off-White Fine PowderPeso molecular:288.05686Acyclovir Related Compound G (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C12H15N5O5Cor e Forma:White Pale Yellow PowderPeso molecular:309.10732Citalopram Related Compound A (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFórmula:C20H23FN2O2Cor e Forma:Cream PowderPeso molecular:342.17436Zolmitriptan Related Compound F (2,2'-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole})
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H53N7O4Cor e Forma:Orange PowderPeso molecular:671.4159Benzalkonium Chloride (5 mL of approx. 4% aqueous solution)
CAS:<p>Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale</p>Cor e Forma:Clear Colorless LiquidMirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C17H19N3O·H2OCor e Forma:Off-White White PowderPeso molecular:281.15281Valacyclovir Related Compound F (2-hydroxyethyl valinate para-toluenesulfonate salt)
CAS:Non-aromatic amino-compounds with oxygen functionFórmula:C7H15NO3·C7H8O3SCor e Forma:White Off-White PowderPeso molecular:161.10519Pramipexole Related Compound F ((6S,7R)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C10H17N3OSCor e Forma:Off-White SolidPeso molecular:227.10923Irinotecan Related Compound A ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C20H16N2O5Cor e Forma:Light Yellow PowderPeso molecular:364.10592Chloropropiophenone (1-(3-Chlorophenyl)propan-1-one)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C9H9ClOCor e Forma:White Yellow SolidPeso molecular:168.03419Testosterone Cypionate Related Compound A (Androst-4-en-3,6-dione-17β-yl 3-cyclopentylpropanoate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFórmula:C27H38O4Cor e Forma:Off-White SolidPeso molecular:426.27701Oxaliplatin Related Compound F ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') diiodidoplatinum(II))
CAS:Inorganic or organic compounds of precious metals, whetFórmula:C6H14N2I2PtCor e Forma:PowderPeso molecular:562.88943Acyclovir Related Compound A (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H13N5O4Cor e Forma:White Crystalline PowderPeso molecular:267.09675Trihexyphenidyl Related Compound A (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C14H19NO·HClCor e Forma:SolidPeso molecular:253.12334Meloxicam Related Compound A (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H13NO5SCor e Forma:White SolidPeso molecular:283.05144Primidone Related Compound A (2-Ethyl-2-phenylmalonamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H14N2O2Cor e Forma:White Crystalline PowderPeso molecular:206.10553Selegiline Related Compound D ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C12H15N·HClCor e Forma:White Off-White PowderPeso molecular:209.09713Letrozole Related Compound A (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H11N5Cor e Forma:White Off-White PowderPeso molecular:285.10145Quetiapine Related Compound B (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H17N3S·2HClCor e Forma:Off-White PowderPeso molecular:295.11432Epinastine Related Compound A ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate)
CAS:AntihistaminesFórmula:C15H16N2·C4H4O4Cor e Forma:Off-White Brown Crystalline PowderPeso molecular:340.14231Linezolid Related Compound C ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H18FN3O3Cor e Forma:White Off-White Light Yellow PowderPeso molecular:295.13322Acitretin Related Compound A ((2Z,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C21H26O3Cor e Forma:Yellow Crystalline PowderPeso molecular:326.18819Triamcinolone Acetonide Related Compound B (9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11β,16α)-pregna-1,4,14-triene-3,20-dione)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives of ketoneFórmula:C24H29FO6Cor e Forma:PowderPeso molecular:432.19482Ropinirole Related Compound B (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride)
CAS:Lactams not elsewhere specified or includedFórmula:C16H22N2O2·HClCor e Forma:Red Brown PowderPeso molecular:274.16813Telmisartan Related Compound A (1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole monohydrate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C19H20N4·H2OCor e Forma:Off-White SolidPeso molecular:322.17936Isradipine Related Compound A (Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylate)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H19N3O5Cor e Forma:White Pale Yellow PowderPeso molecular:369.38Trifluridine Related Compound A (5-Carboxy-2'-deoxyuridine)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C10H12N2O7Cor e Forma:White Off-White PowderPeso molecular:272.06445Quinapril Related Compound A (Ethyl [3S-[(2R*), 3a, 11ab]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C25H28N2O4Cor e Forma:White PowderPeso molecular:420.20491Clonazepam Related Compound B (2-Amino-2'-chloro-5-nitrobenzophenone)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H9ClN2O3Cor e Forma:Yellow PowderPeso molecular:276.030173-O-Methylmethyldopa
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C11H15NO4·H2OCor e Forma:White PowderPeso molecular:225.10011Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H12N2O2Cor e Forma:White PowderPeso molecular:216.08988Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H18ClN3O3SCor e Forma:White Off-White SolidPeso molecular:391.07574Tetrahydrozoline Related Compound B (2-(1,2,3,4-Tetrahydronaphthalen-1-yl)-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C13H14N2Cor e Forma:Off-White White PowderPeso molecular:198.1157Valsartan Related Compound A (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}D-valine)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C24H29N5O3Cor e Forma:Off-White PowderPeso molecular:435.22704Cetirizine Related Compound A ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C25H31ClN2O7Cor e Forma:White PowderPeso molecular:506.98Famotidine Related Compound F (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C8H12N4O2S2Cor e Forma:White PowderPeso molecular:260.04017Captopril Disulfide
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C18H28N2O6S2Cor e Forma:White Solid Crystalline PowderPeso molecular:432.13888Acetaminophen Related Compound B (N-(4-hydroxyphenyl)propanamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C9H11NO2Cor e Forma:White Brown PowderPeso molecular:165.07898Diatrizoic Acid Related Compound A (5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C9H7I3N2O3Cor e Forma:Off-White Light Yellow PowderPeso molecular:571.75908Rivaroxaban Open Ring S-isomer ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H20ClN3O4SCor e Forma:White Off-White SolidPeso molecular:409.0863Rivaroxaban Open Chain Dithiophene Analog ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C25H24Cl2N4O6S2Cor e Forma:White Off-White SolidPeso molecular:610.05143Torsemide Related Compound A (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C12H13N3O2SCor e Forma:White PowderPeso molecular:263.07285Entecavir Related Compound A (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C27H31N5O2SiCor e Forma:White Light Yellow PowderPeso molecular:485.2247Ranitidine Related Compound A (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFórmula:C10H18N2OSC4H4O4Cor e Forma:Off-White Crystalline PowderPeso molecular:272.36Bendamustine Related Compound C (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C18H27N3O4Cor e Forma:White PowderPeso molecular:349.20016Tetrahydrozoline Related Compound C (1,2,3,4-Tetrahydronaphthalene-1-carboxylic acid)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFórmula:C11H12O2Cor e Forma:White SolidPeso molecular:176.08373Potassium Ferrocyanide
CAS:Complex cyanidesFórmula:K4Fe(CN)6·3H2OCor e Forma:Yellow CrystalsPeso molecular:421.8399Dolasetron Mesylate Related Compound A (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3 (4H)-one, hydrochloride)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C10H15NO2·HClCor e Forma:White Crystalline PowderPeso molecular:181.11028Abacavir Related Compound D (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chloropyrimidin-4-yloxy)methyl]cyclopent-2-enyl}-9H-purine-2,6-diamine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C18H21ClN10OCor e Forma:Red Orange Brown PowderPeso molecular:428.15883Almotriptan Related Compound C (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C16H23N3O2SCor e Forma:SolidPeso molecular:321.1511Nitazoxanide Related Compound A (5-Nitrothiazole-2-amine)
CAS:Compounds containing an unfused thiazole ring (whetherFórmula:C3H3N3O2SCor e Forma:Yellow PowderPeso molecular:145.15 g/molAlmotriptan Related Compound A ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol)
CAS:Sulfonamides, nesoiFórmula:C18H27N3O3SCor e Forma:White Crystalline PowderPeso molecular:365.17731Isoguaifenesin
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C10H14O4Cor e Forma:Off-White PowderPeso molecular:198.08921Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C36H36N6O10Cor e Forma:Off-White SolidPeso molecular:712.24929Nateglinide Related Compound A (trans-4-isopropylcyclohexanecarboxylic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acidFórmula:C10H18O2Cor e Forma:White CrystalsPeso molecular:170.13068Ketorolac Related Compound D (5-benzoyl-2,3-dihydro-1H-pyrrolizine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C14H13NOCor e Forma:White Light Brown PowderPeso molecular:211.09971Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C11H15NOCor e Forma:Off-White PowderPeso molecular:177.11536Granisetron Related Compound D (1-Methyl-1H-indazole-3-carboxylic acid)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C9H8N2O2Cor e Forma:Pale Yellow PowderPeso molecular:176.05858Dexmedetomidine Related Compound C (5-[1-(2,3-Dimethylphenyl)ethyl]-1-ethyl-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C15H20N2Cor e Forma:White SolidPeso molecular:228.16265Fluoxetine Related Compound C (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C21H22F3NO4Cor e Forma:PowderPeso molecular:409.41Methoxymethylguanine
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C7H9N5O2Cor e Forma:Light Yellow PowderPeso molecular:195.07562Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C7H11NO6P2Cor e Forma:White Crystalline PowderPeso molecular:267.00616Cidofovir Enantiomer (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C8H14N3O6PCor e Forma:White Off-White PowderPeso molecular:279.06202Triamterene Related Compound B (2,7-diamino-4-hydroxy-6-phenylpteridine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C12H10N6OCor e Forma:Light Yellow Crystalline PowderPeso molecular:254.09161Dipyridamole Related Compound F (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C21H36N8O5Cor e Forma:SolidPeso molecular:480.28087Amoxicillin Related Compound B (L-amoxicillin)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H19O5N3SCor e Forma:PowderPeso molecular:365.10454Roflumilast Related Compound B (N-(3,5-Dichloropyridin-4-yl)-4-(difluoromethoxy)-3-hydroxybenzamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C13H8Cl2F2N2O3Cor e Forma:White PowderPeso molecular:347.988Famciclovir Related Compound F (2-Amino-6-chloropurine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C5H4ClN5Cor e Forma:Light Yellow Off-White PowderPeso molecular:169.01552Ziprasidone Related Compound F (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H22ClN4NaO2S·H2OCor e Forma:White Off-White SolidPeso molecular:470.11553Estriol Related Compound A (Estra-1,3,5(10),9(11)-tetraene-3,16α,17β-triol)
CAS:Estrogens and progestinsFórmula:C18H22O3Cor e Forma:Cream Off-White PowderPeso molecular:286.15689Celecoxib Related Compound C (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C18H16F3N3O2SCor e Forma:SolidPeso molecular:395.09153Amlodipine Related Compound C (Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H18ClNO4Cor e Forma:Off-White Yellow Crystalline PowderPeso molecular:335.09244Azithromycin N-Oxide
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H72N2O13Cor e Forma:White Crystalline PowderPeso molecular:764.50344Desbenzyl Donepezil Hydrochloride
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H23NO3·HClCor e Forma:Yellow Off-White PowderPeso molecular:325.14447Sotalol Related Compound B (N-(4-Formylphenyl)methanesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C8H9NO3SCor e Forma:Yellow Crystalline PowderPeso molecular:199.03031Benazepril Related Compound C ((S)-2-{[(S)-1-(Carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl]amino}-4-phenylbutanoic acid)
CAS:Lactams, nesoiFórmula:C22H24N2O5Cor e Forma:White Clumpy PowderPeso molecular:396.16852Beclomethasone Dipropionate Related Compound A (9-Chloro-11β,17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C25H33ClO6Cor e Forma:White Off-White PowderPeso molecular:464.19657Methylphenidate Hydrochloride Erythro Isomer Solution
CAS:Produto ControladoCompounds containing an unfused pyridine ring in the structure, nesoiFórmula:C14H19NO2·HClCor e Forma:Clear LiquidPeso molecular:269.11826Atenolol Related Compound G (2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}acetic acid)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C14H21NO4Cor e Forma:White SolidPeso molecular:267.14706Clindamycin 2,3-Dipalmitate (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C50H93ClN2O7S·HClCor e Forma:White Off-White SolidPeso molecular:936.61588Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H18N2O3SCor e Forma:PowderPeso molecular:270.103811-Mononitroglycerin
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFórmula:C3H7NO5Cor e Forma:Clear Colorless LiquidPeso molecular:137.03242Methylene Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate)
CAS:Lactones nesoiFórmula:C25H36O5Cor e Forma:White PowderPeso molecular:416.25627Paliperidone Related Compound A (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-α]pyrimidin-4-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C11H16N2O2Cor e Forma:Off-White PowderPeso molecular:208.12118Rivaroxaban
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H18ClN3O5SCor e Forma:White PowderPeso molecular:435.06557Lanolin Alcohols
CAS:Wool grease, except crude, and fatty substances derivedCor e Forma:Pale Yellow Brownish Yellow Waxy SolidDimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C8H9ClN4O2Cor e Forma:White Off-White PowderPeso molecular:228.0414Trandolapril Related Compound A ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C23H32N2O5Cor e Forma:Crystalline PowderPeso molecular:416.23112Cetirizine Related Compound C (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C21H26ClN3O2Cor e Forma:PowderPeso molecular:387.17135Betamethasone Dipropionate Related Compound C (9-Fluoro-11β,17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate)
CAS:Halogenated derivatives of adrenal cortical hormonesFórmula:C25H33FO6Cor e Forma:White PowderPeso molecular:448.22612Bendamustine Related Compound A (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C16H23N3O4HClCor e Forma:White SolidPeso molecular:357.83Perindopril Related Compound E ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-Isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C20H34N2O5·C4H11NCor e Forma:White PowderPeso molecular:382.24677Eletriptan Related Compound B ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H17BrN2Cor e Forma:Light Yellow PowderPeso molecular:292.05751Methylprednisolone Hemisuccinate Related Compound B (11β,21-Dihydroxy-6α-methyl-3,20-dioxopregna-1,4-dien-17-yl hydrogen succinate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C26H34O8Cor e Forma:White SolidPeso molecular:474.22537Mesna Related Compound B (2,2'-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride)
Organo-sulfur compounds, nesoiFórmula:C4H8K2O6S4·NaClCor e Forma:White PowderPeso molecular:415.80641Abacavir Related Compound B ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H14ON4ClCor e Forma:Cream PowderPeso molecular:241.08561Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
CAS:Compounds containing an unfused imidazole ring (whetherFórmula:C20H20Cl4N6Cor e Forma:White Off-White PowderPeso molecular:486.23Prochlorperazine Related Compound A (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C20H24ClN3S·2HClCor e Forma:Light Grey PowderPeso molecular:373.13795Ropivacaine Related Compound B ((R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H26N2O·HCl·H2OCor e Forma:White PowderPeso molecular:274.20451Meclizine Related Compound A (4-Chlorobenzhydrol)
CAS:Compounds containing a pyrimidine ring (whether or notFórmula:C13H11ClOCor e Forma:White PowderPeso molecular:218.04984Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid)
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C3H9NO3SCor e Forma:PowderPeso molecular:139.03031Imiquimod Related Compound D (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine)
CAS:<p>Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Fórmula:C13H14N4Cor e Forma:Off-White PowderPeso molecular:226.12185Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFórmula:C27H29BrN4O5Cor e Forma:Cream PowderPeso molecular:568.13213Glycopyrrolate Related Compound B (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride)
CAS:Aromatic polycarboxylic acids, their anhydrides, halideFórmula:C18H25NO3Cor e Forma:Off-White PowderPeso molecular:303.18344Phenyltoloxamine Related Compound A (2-(2-Benzylphenoxy)ethylmethylamine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C16H19NO·HClCor e Forma:White Light Yellow PowderPeso molecular:241.14666Bosentan Related Compound E (4-(tert-butyl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C10H15NO2SCor e Forma:PowderPeso molecular:213.08235Tacrolimus 8-epimer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C44H69NO12Cor e Forma:White PowderPeso molecular:803.48198Aminophenylmorpholinone (4-(4-aminophenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H12N2O2Cor e Forma:White Off-White SolidPeso molecular:192.08988Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS:Lactams not elsewhere specified or includedFórmula:C15H10ClN3O3Cor e Forma:Yellow-Orange PowderPeso molecular:315.04107Triethylamine
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C6H15NCor e Forma:Clear Colorless LiquidPeso molecular:101.12045Amlodipine Related Compound B (3-Ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-({2-[2-(methylcarbamoyl)benzamido]ethoxy}methyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:<p>Compounds containing an unfused pyridine ring in the structure, nesoi</p>Fórmula:C29H32ClN3O7Cor e Forma:White PowderPeso molecular:569.19288Trazodone Related Compound F (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C13H18Cl2N2·ClHCor e Forma:White PowderPeso molecular:308.06138Lisinopril Related Compound A ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-α]pyrazin-2(1H)-yl}-4-phenylbutanoic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C21H29N3O4Cor e Forma:Yellow Off-White Crystalline PowderPeso molecular:387.21581Azacitidine Related Compound C (1-β-D-Ribofuranosyl-3-guanylurea picrate)
CAS:Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers and sugar esters, and their salts, nesoiFórmula:C7H14N4O5·C6H3N3O7Cor e Forma:Yellow PowderPeso molecular:234.09642Methoxsalen Related Compound B (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one)
CAS:Aromatic lactones used as drugsFórmula:C13H10O5Cor e Forma:PowderPeso molecular:246.05282Decitabine Related Compounds B and C Mixture (4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one and 4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-a-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H18Cl2N4O6andC22H18Cl2N4O6Cor e Forma:White PowderPeso molecular:504.06034Nepafenac Related Compound B (7-Benzoylindolin-2-one)
CAS:Lactams not elsewhere specified or includedFórmula:C15H11NO2Cor e Forma:Pink SolidPeso molecular:237.07898Palonosetron Enantiomer ((3aR)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
CAS:Lactams not elsewhere specified or includedFórmula:C19H24N2O·HClCor e Forma:Off-White SolidPeso molecular:332.16554Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C22H32N2O4Cor e Forma:White SolidPeso molecular:388.23621Benzhydrol
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C13H12OCor e Forma:White Off-White PowderPeso molecular:184.08882Famciclovir Related Compound C (4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate)
CAS:Compounds containing a pyrimidine ring (whether or notFórmula:C12H17N5O2Cor e Forma:White Light Yellow PowderPeso molecular:263.13822Verapamil Related Compound E (3,4-dimethoxybenzaldehyde)
CAS:Aldehyde-ethers, aldehyde-phenols and aldehydes with otFórmula:C9H10O3Cor e Forma:PowderPeso molecular:166.06299Phenylbutyrate Related Compound C (4-cyclohexylbutanoic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFórmula:C10H18O2Cor e Forma:White PowderPeso molecular:170.13068Indole
CAS:Acridine (10-azaanthracene) and indole (2,3-benzopyrrole)Fórmula:C8H7NCor e Forma:White Crystalline PowderPeso molecular:117.05785N-Ethylpiperazine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C6H14N2Cor e Forma:Colorless LiquidPeso molecular:114.1157Cyclizine Related Compound A (1-Methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C5H12N2Cor e Forma:Colorless Clear Pale Yellow LiquidPeso molecular:100.10005Dipyridamole Related Compound C (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C20H30ClN7O2Cor e Forma:Light Yellow SolidPeso molecular:435.21495Norfloxacin Related Compound H (7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C19H22FN3O5Cor e Forma:Off-White PowderPeso molecular:391.15435Metformin Hydrochloride
CAS:Non-aromatic imines and their derivatives; salts thereof, nesoiFórmula:C4H11N5·HClCor e Forma:White Off-White PowderPeso molecular:129.10145Losartan Related Compound E (4'-[({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1- yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C44H43Cl2KN12OCor e Forma:PowderPeso molecular:864.26969Desosaminylazithromycin ((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-dimethylamino-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C30H58N2O9Cor e Forma:White Off-White PowderPeso molecular:590.41423Vecuronium Bromide Related Compound C (Piperidinium, 1-[(2β,3α,5α,16β,17β)-3,17-dihydroxy-2-(1-piperidinyl) androstan-16-yl]-1-methyl bromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C30H53BrN2O2Cor e Forma:White Off-White PowderPeso molecular:552.32904Phentermine Related Compound A (N-(2-Methyl-1-phenylpropan-2-yl)formamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H15NOCor e Forma:White Off-White PowderPeso molecular:177.11536Budesonide Related Compound G (16α,17-[butylidenebis(oxy)]-11β, 21-dihydroxypregna-4-ene-3,20-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C25H36O6Cor e Forma:Off-White PowderPeso molecular:432.25119Progesterone Related Compound H (Pregna-4,6-diene-3,20-dione)
CAS:Estrogens and progestinsFórmula:C21H30O2Cor e Forma:Pale Yellow Off-White PowderPeso molecular:314.22458Verteporfin Related Compound A ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C40H40N4O8Cor e Forma:Dark Green PowderPeso molecular:704.77Phentermine Related Compound C ((2-Methylprop-1-en-1-yl)benzene)
CAS:Cyclic hydrocarbons not elsewhere specified or includedFórmula:C10H12Cor e Forma:Colorless LiquidPeso molecular:132.0939Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS:Lactones, nesoiFórmula:C27H40O6Cor e Forma:PowderPeso molecular:460.28249Dabigatran Etexilate Mesylate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H41N7O5·CH4O3SCor e Forma:White Off-White Yellow PowderPeso molecular:723.30503Moxifloxacin Related Compound B (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFórmula:C22H27N3O5·HCl·H2OCor e Forma:SolidPeso molecular:413.19507Tacrolimus Related Compound A (See USP Certificate for full Chemical Name)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C43H69NO12Cor e Forma:White Light Yellow PowderPeso molecular:791.48198Cefaclor δ-3 Isomer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H14ClN3O4SCor e Forma:Off-White Tan PowderPeso molecular:367.03935Pravastatin Related Compound A (Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C23H35NaO7Cor e Forma:White Off-White PowderPeso molecular:446.22805Chlorzoxazone Related Compound A (2-Amino-4-chlorophenol)
CAS:Amino-naphthols and other amino-phenols, their ethers aFórmula:C6H6ClNOCor e Forma:Brown Crystalline PowderPeso molecular:143.01379Mafenide Related Compound A (4-Formylbenzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C7H7NO3SCor e Forma:White PowderPeso molecular:185.2Sumatriptan Succinate Related Compound C ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
CAS:Sulfonamides, nesoiFórmula:C15H23N3O3S(C4H6O4)Cor e Forma:Off-White PowderPeso molecular:384.47Metaraminol Related Compound A ((E)-1-[3-(benzyloxy)phenyl]-2-(hydroxyimino)propan-1-one)
CAS:Aromatic imines and their derivatives, salts thereofFórmula:C16H16NO3Cor e Forma:Off-White SolidPeso molecular:270.11302Metaraminol Related Compound B (2-Amino-1-[3-(benzyloxy)phenyl]propan-1-ol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C15H19NO2Cor e Forma:White SolidPeso molecular:245.14158Aripiprazole Related Compound H (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one)
Lactams, nesoiFórmula:C27H35Cl2N3O3Cor e Forma:White Pale Yellow Crystalline PowderPeso molecular:519.205554-Hydrazinylbenzenesulfonamide Hydrochloride
CAS:Sulfonamides, nesoiFórmula:C6H9N3O2S·HClCor e Forma:Light Yellow Beige Crystalline PowderPeso molecular:223.01823Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H10ClNOCor e Forma:Light Yellow PowderPeso molecular:243.04509Nitazoxanide Related Compound B (2-Hydroxy-N-(5-nitrothiazol-2-yl) benzamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C10H7N3O4SCor e Forma:Pale Yellow PowderPeso molecular:265.01573Acebutolol Related Compound B (N-{3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide)
CAS:Compounds containing a pyrimidine ring (whether or notFórmula:C16H24N2O4Cor e Forma:PowderPeso molecular:308.17361Zileuton Related Compound B (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H10OS2Cor e Forma:Yellow Brown PowderPeso molecular:294.01731Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C20H21F2N3O3Cor e Forma:White Off-White PowderPeso molecular:389.1551Cyproheptadine Related Compound C (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol)
CAS:Cyclanic, cyclenic or cycloterpenic ketones without other oxygen function not elsewhere specified or includedFórmula:C21H23NOCor e Forma:Off-White PowderPeso molecular:305.17796Prostaglandin A1
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C20H32O4Cor e Forma:White PowderPeso molecular:336.23006Dinoprostone Related Compound C ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C20H32O5Cor e Forma:SolidPeso molecular:352.22497Estazolam Related Compound A (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C16H11Cl2N3OCor e Forma:Light Yellow Off-White White Crystalline PowderPeso molecular:331.02792N-Nitroso Diclofenac (2-(2-((2,6-dichlorophenyl) (nitroso)amino)phenyl)acetic acid)
CAS:Compounds with other nitrogen function, nesoiFórmula:C14H10Cl2N2O3Cor e Forma:Off-White PowderPeso molecular:324.00685Norscopolamine ((1R ,2R ,4S ,5S ,7s )-3-Oxa-9-azatricyclo[3.3.1.0^2,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate)
CAS:Aromatic or modified aromatic heterocyclic compounds with nitrogen hetero atom(s) only, except acridine, indole and carbazoleFórmula:C16H19NO4Cor e Forma:White Off-White PowderPeso molecular:289.13141Transplatin
CAS:Inorganic or organic compounds of precious metals, whether or not chemically defined, or amalgams of precious metals, nesoiFórmula:Cl2H6N2PtCor e Forma:Light Yellow PowderPeso molecular:300.05Ketorolac Related Compound A (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C19H22N2O5Cor e Forma:White PowderPeso molecular:358.15287Fosinopril Related Compound E ((4S)-4-Phenyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C30H39NNaO7PCor e Forma:White PowderPeso molecular:579.23618Doxazosin Related Compound D (1,4-benzodioxane-2-carboxylic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C9H8O4Cor e Forma:Off-White Crystalline PowderPeso molecular:180.04226p-Ranolazine (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C24H33N3O4Cor e Forma:White PowderPeso molecular:427.24711Nateglinide Related Compound B (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C19H27NO3Cor e Forma:White PowderPeso molecular:317.19909Lorazepam Related Compound A (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepin-2-one)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H12Cl2N2O3Cor e Forma:Off-White PowderPeso molecular:362.0225Balsalazide Related Compound B ((E)-5-({m-[(2-Carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid)
CAS:Diazo-, azo-, or azoxy-compoundsFórmula:C17H15N3O6Cor e Forma:Orange Brown PowderPeso molecular:357.09609Celecoxib Related Compound D ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C15H17N3O2SCor e Forma:Pale Yellow Off-White SolidPeso molecular:303.10415Benzophenone (Diphenylmethanone)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C13H10OCor e Forma:Colorless White Crystalline Powder CrystalsPeso molecular:182.07316Lovastatin Related Compound A (4,4a-Dihydrolovastatin)
Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C24H38O5Cor e Forma:White Crystalline PowderPeso molecular:406.27192Cefuroxime Axetil δ-3-Isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H22N4O10SCor e Forma:Tan PowderPeso molecular:510.10566Ticagrelor Related Compound B
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C23H28F2N6O4SCor e Forma:White Off-White Crystalline PowderPeso molecular:522.18608Dalfampridine Related Compound B (3,5-Dibromopyridin-4-amine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C5H4Br2N2Cor e Forma:Off-White SolidPeso molecular:249.87412N-Demethylazithromycin
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C37H70N2O12Cor e Forma:White PowderPeso molecular:734.49288Tinidazole Related Compound B (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C8H13N3O4SCor e Forma:Off-White Cream PowderPeso molecular:247.06268Bisoprolol Related Compound E (3,3'-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol))
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C33H53NO8Cor e Forma:Colorless Gummy LiquidPeso molecular:591.37712Rivaroxaban Open Ring Methylamine ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H21N3O3Cor e Forma:White Off-White SolidPeso molecular:279.15829Roflumilast Related Compound E (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H14BrClF2N2O3Cor e Forma:White Beige PowderPeso molecular:445.98444Pyridostigmine Related Compound B (3-Hydroxy-1-methylpyridin-1-ium bromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C6H8BrNOCor e Forma:White Off-White SolidPeso molecular:188.97893Ecamsule Related Compound A (1,4-Phenylenedimethanol)
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C8H10O2Cor e Forma:White Crystalline PowderPeso molecular:138.06808Amitriptyline Related Compound B (5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C20H25NOCor e Forma:White PowderPeso molecular:295.19361Praziquantel Related Compound A (2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a]isoquinolin-4-one)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C19H18N2O2Cor e Forma:White Crystalline PowderPeso molecular:306.13683
![Acyclovir Related Compound G (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl ac…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1012087.webp&w=3840&q=75)
![Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]be…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1444235.webp&w=3840&q=75)
![Ropinirole Related Compound B (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1605227.webp&w=3840&q=75)
![Telmisartan Related Compound A (1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole monohydrat…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1643420.webp&w=3840&q=75)
![Almotriptan Related Compound C (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}etha…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1013556.webp&w=3840&q=75)
![Almotriptan Related Compound A ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1013523.webp&w=3840&q=75)
![Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604643.webp&w=3840&q=75)
![Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078835.webp&w=3840&q=75)
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
